| abstract |
The present invention relates to substituted phosphoramidic acids— (2R, 3R, 5R) -3-hydroxy- (5-pyrimidin-1-yl) tetrahydrofuran-2-yl) methylaryl phosphoramidates of formula 1 or formula 2 (S)-(2R, 3R, 5R) -3-hydroxy- (5-pyrimidin-1-yl) tetrahydrofuran-2-yl) methylaryl phosphoramidate, or a pharmaceutically acceptable salt thereof, water The present invention relates to a novel compound representing a solvate, a crystalline form or a stereoisomer. |